Outlook Therapeutics, Inc.
OTLK- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001649989
In the last 90 days, Outlook Therapeutics, Inc. insiders filed 4 open-market purchases and 0 sales; 68 institutions reported holding it in 13F filings for Q2 2026, worth $32.2M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Outlook Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 87 | 1 | 81 | −5 |
| Shares | 29.4M | 20.0K | 27.5M | −1.81M (−6.2%) |
| Value | $51.1M | $35.0K | $6.11M | −$45.0M (−88.0%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (13)
Institutions that held Outlook Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Gsa Capital Partners LLP | 259,394 | $57.0K | 0.00% |
| Neuberger Berman Group LLC | 28,265 | $6.25K | 0.00% |
| D.A. Davidson & Co. | 28,000 | $6.19K | 0.00% |
| Level Four Advisory Services, LLC | 23,696 | $5.24K | 0.00% |
| SG Americas Securities, LLC | 19,993 | $4.00K | 0.00% |
| TownSquare Capital, LLC | 17,182 | $3.80K | 0.00% |
| Citadel Advisors LLC | 13,517 | $2.99K | 0.00% |
| Zacks Investment Management | 12,000 | $2.65K | 0.00% |
| GTS Securities LLC | 10,652 | $2.35K | 0.00% |
| Allspring Global Investments Holdings, LLC | 10,339 | $2.28K | 0.00% |
| CWM, LLC | 5,660 | $1.00K | 0.00% |
| Armstrong Advisory Group, Inc | 3,580 | $792 | 0.00% |
| SOA Wealth Advisors, LLC. | 3,500 | $774 | 0.00% |
Sold out (18)
Institutions that held Outlook Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| LVW Advisors, LLC | 1,733,633 | $3.02M |
| Nuveen Asset Management, LLC | 598,961 | $1.04M |
| Squarepoint Ops LLC | 316,573 | $550.8K |
| Millennium Management LLC | 143,733 | $250.1K |
| MetLife Investment Management | 83,435 | $145.2K |
| Voya Investment Management LLC | 65,561 | $114.1K |
| Manufacturers Life Insurance Company, The | 65,368 | $113.7K |
| Susquehanna International Group, LLP | 54,218 | $94.3K |
| Verition Fund Management LLC | 53,600 | $93.3K |
| State Board of Administration of Florida Retirement System | 44,030 | $76.6K |
| Jane Street Group, LLC | 23,639 | $41.1K |
| Alamar Capital Management, LLC | 20,000 | $34.8K |
| Exencial Wealth Advisors, LLC | 15,221 | $26.5K |
| SEI Investments Co | 10,549 | $18.4K |
| Transcend Wealth Collective, LLC | 10,000 | $17.4K |
| Metropolitan Life Insurance Co | 8,584 | $14.9K |
| UBS Group AG | 5,035 | $8.76K |
| NewSquare Capital LLC | 200 | $348 |
Not filed for Q3 2023 yet (1)
Institutions that held Outlook Therapeutics, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Endurance Wealth Management, Inc. | 20,000 | $35.0K |